Dataset Information


Establishment of replication-competent vesicular stomatitis virus-based recombinant viruses suitable for SARS-CoV-2 entry and neutralization assays.

ABSTRACT: Replication-competent vesicular stomatitis virus (VSV)-based recombinant viruses are useful tools for studying emerging and highly pathogenic enveloped viruses in level 2 biosafety facilities. Here, we used a replication-competent recombinant VSVs (rVSVs) encoding the spike (S) protein of SARS-CoV-2 in place of the original G glycoprotein (rVSV-eGFP-SARS-CoV-2) to develop a high-throughput entry assay for SARS-CoV-2. The S protein was incorporated into the recovered rVSV-eGFP-SARS-CoV-2 particles, which could be neutralized by sera from convalescent COVID-19 patients. The recombinant SARS-CoV-2 also displayed entry characteristics similar to the wild type virus, such as cell tropism and pH-dependence. The neutralizing titers of antibodies and sera measured by rVSV-eGFP-SARS-CoV-2 were highly correlated with those measured by wild-type viruses or pseudoviruses. Therefore, this is a safe and convenient screening tool for SARS-CoV-2, and it may promote the development of COVID-19 vaccines and therapeutics.


PROVIDER: S-EPMC7594855 | BioStudies | 2020-01-01

REPOSITORIES: biostudies

Similar Datasets

2020-01-01 | S-EPMC7332447 | BioStudies
2020-01-01 | S-EPMC7263493 | BioStudies
2020-01-01 | S-EPMC7391951 | BioStudies
2020-01-01 | S-EPMC7359519 | BioStudies
2022-02-05 | E-MTAB-10740 | ArrayExpress
2005-01-01 | S-EPMC7112911 | BioStudies
2020-01-01 | S-EPMC7745033 | BioStudies
2020-01-01 | S-EPMC7217240 | BioStudies
2021-01-01 | S-EPMC7871913 | BioStudies
2020-01-01 | S-EPMC7600936 | BioStudies